591 related articles for article (PubMed ID: 22605933)
21. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
[TBL] [Abstract][Full Text] [Related]
22. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
24. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
Diab RF; Abdelghany TM; Gad S; Elbakry AM
J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
[TBL] [Abstract][Full Text] [Related]
25. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
Severino P; Santana MH; Souto EB
Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
[TBL] [Abstract][Full Text] [Related]
26. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies.
Rigon RB; Fachinetti N; Severino P; Santana MH; Chorilli M
Molecules; 2016 Jan; 21(1):E116. PubMed ID: 26805794
[TBL] [Abstract][Full Text] [Related]
27. Comparative Study of Glyceryl Behenate or Polyoxyethylene 40 Stearate-Based Lipid Carriers for Trans-Resveratrol Delivery: Development, Characterization and Evaluation of the In Vitro Tyrosinase Inhibition.
Fachinetti N; Rigon RB; Eloy JO; Sato MR; Dos Santos KC; Chorilli M
AAPS PharmSciTech; 2018 Apr; 19(3):1401-1409. PubMed ID: 29404955
[TBL] [Abstract][Full Text] [Related]
28. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
[TBL] [Abstract][Full Text] [Related]
29. Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles.
Andrade LM; de Fátima Reis C; Maione-Silva L; Anjos JL; Alonso A; Serpa RC; Marreto RN; Lima EM; Taveira SF
Eur J Pharm Biopharm; 2014 Sep; 88(1):40-7. PubMed ID: 24816130
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
31. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles.
Elnaggar YS; El-Massik MA; Abdallah OY
Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508
[TBL] [Abstract][Full Text] [Related]
32. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
33. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
[TBL] [Abstract][Full Text] [Related]
34. Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting.
Sharma AN; Upadhyay PK; Dewangan HK
J Microencapsul; 2022 Sep; 39(6):563-574. PubMed ID: 36222429
[TBL] [Abstract][Full Text] [Related]
35. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
Arora R; Katiyar SS; Kushwah V; Jain S
Expert Opin Drug Deliv; 2017 Feb; 14(2):165-177. PubMed ID: 27882780
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Effect of Resveratrol-Loaded Solid Lipid Nanoparticles to Relieve Physical Fatigue for Sports Nutrition Supplements.
Qin L; Lu T; Qin Y; He Y; Cui N; Du A; Sun J
Molecules; 2020 Nov; 25(22):. PubMed ID: 33202918
[TBL] [Abstract][Full Text] [Related]
38. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
39. [Study on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitro].
Zhang QH; Xiong QP; Shi YY; Zhang DY
Zhong Yao Cai; 2010 Dec; 33(12):1929-32. PubMed ID: 21548373
[TBL] [Abstract][Full Text] [Related]
40. Phytocannabinoids: Chromatographic Screening of Cannabinoids and Loading into Lipid Nanoparticles.
Zielińska A; da Ana R; Fonseca J; Szalata M; Wielgus K; Fathi F; Oliveira MBPP; Staszewski R; Karczewski J; Souto EB
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
